AGPU - Predictive Oncology Inc.
7.1
-1.650 -23.239%
Share volume: 3,806,034
Last Updated: 04-23-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.01%
PREVIOUS CLOSE
CHG
CHG%
$8.75
-1.65
-0.19%
Fundamental analysis
25%
Profitability
25%
Dept financing
23%
Liquidity
11%
Performance
30%
Performance
5 Days
53.68%
1 Month
364.05%
3 Months
44.90%
6 Months
-11.36%
1 Year
551.38%
2 Year
429.85%
Key data
Stock price
$7.10
DAY RANGE
$6.60 - $7.62
52 WEEK RANGE
$0.71 - $16.54
52 WEEK CHANGE
$569.81
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
Company detail
CEO: Raymond F. Vennare
Region: US
Website: predictive-oncology.com
Employees: 30
IPO year: 2010
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: predictive-oncology.com
Employees: 30
IPO year: 2010
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Predictive Oncology Inc. focuses on developing personalized cancer therapies using artificial intelligence (AI) The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures.
Recent news